Researchers at Johns Hopkins found a single dose of psilocybin dramatically increased smoking cessation rates compared with nicotine patches. In a randomized trial of 82 smokers, 17 of 41 participants who received psilocybin remained abstinent after six months versus four of 41 on patches, a more than six‑fold advantage. All participants also received 13 weeks of cognitive‑behavioral therapy, and the study was published in JAMA Network Open. The authors note the need for larger, more diverse trials to confirm findings.
Primary care physicians are feeling the squeeze from projected Medicaid cuts and low insurer reimbursement rates, prompting practices like Valley Medical Group in western Massachusetts to lay off 40 staff members, roughly 10% of its workforce. To regain bargaining power...
Sauna use has surged as a wellness trend, prompting scientific scrutiny of its health impacts. Large Finnish cohort studies show that bathing 4‑7 times weekly cuts cardiovascular disease risk by up to 60% and improves blood pressure, cholesterol, and arterial...